AGEN · Agenus Inc
United States · RS rating 88 · As of 2026-10-14
| Price | 6.50 USD |
|---|---|
| 1-day change | -6.5% |
| RS rating (overall / 1M / 3M / 12M) | 88 / 25 / 93 / 91 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 33 / 37 / 30 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -101.0% |
| Sales growth Q/Q | +13.1% |
| Distance from 52-week high | +34.5% |
| Market cap (USD) | $144.4M |